⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL914857 | 0.94 | — | — | |
| SCHEMBL2688792 | 0.81 | — | — | |
| SCHEMBL6539087 | 0.80 | — | — | |
| SCHEMBL3944531 | 0.78 | — | — | |
| SCHEMBL9801988 | 0.78 | ALDH1A1 (0.32) | — | |
| SCHEMBL31038348 | 0.76 | — | — | |
| SCHEMBL7594180 | 0.74 | — | — | |
| SCHEMBL754863 | 0.74 | — | — | |
| SCHEMBL16615429 | 0.74 | — | — | |
| SCHEMBL15479011 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2046147-B1 | METHOD OF USING ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2013-05-01 | — | — | EP | claimed |
| US-20090311403-A1 | Method of Using Organic Compounds | GIVAUDAN SA (CH) | 2009-12-17 | — | — | US | claimed |
| CN-101494999-A | Method for using organic compound | GIVAUDAN SA (CH) | 2009-07-29 | — | — | CN | claimed |
| EP-2046147-A1 | METHOD OF USING ORGANIC COMPOUNDS | Givaudan SA (CH) | 2009-04-15 | — | — | EP | claimed |
| WO-2008011742-A1 | METHOD OF USING ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2008-01-31 | — | — | WO | claimed |
| CN-113861343-B | Urethane (meth) acrylate, active energy ray-curable resin composition, cured product, and laminate | 荒川化学工业株式会社 | 2023-11-10 | — | — | CN | disclosed |
| WO-2023205465-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2023-10-26 | — | — | WO | disclosed |
| CN-116893576-A | Positive resist material and pattern forming method | 信越化学工业株式会社 | 2023-10-17 | — | — | CN | disclosed |
| US-20230314944-A1 | POSITIVE RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-10-05 | — | — | US | disclosed |
| CN-113861343-A | Urethane (meth) acrylate, active energy ray-curable resin composition, cured product, and laminate | 荒川化学工业株式会社 | 2021-12-31 | — | — | CN | disclosed |
| EP-2046147-B1 | METHOD OF USING ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2013-05-01 | — | — | EP | disclosed |
| EP-2253607-B1 | METHOD OF CONVERTING ETHYLBENZENE AND PROCESS FOR PRODUCING P-XYLENE | TORAY INDUSTRIES (JP) | 2012-06-20 | — | — | EP | disclosed |
| US-5064834-A | That block mu or kappa receptors in the brain | ELI LILLY AND COMPANY (US) | 1991-11-12 | — | — | US | disclosed |
| US-4992450-A | Piperidine opioid antagonists | ELI LILLY AND COMPANY (US) | 1991-02-12 | — | — | US | disclosed |
| US-4891379-A | BLOCKING MU OR KAPPA RECEPTORS | KABUSHIKI KAISHA KOBE SEIKOSHO (JP) | 1990-01-02 | — | — | US | disclosed |
| EP-0287339-A2 | Piperidine opioid antagonists | ELI LILLY AND COMPANY (US) | 1988-10-19 | — | — | EP | disclosed |
| US-4532272-A | Creation and maintenance of the bed of a particle form evaporator | PHILLIPS PETROLEUM COMPANY (US) | 1985-07-30 | — | — | US | disclosed |
| US-4220727-A | CARBOXYALKYL SILOXANES, ALIPHATIC GLYOXIMES, ARALKYL QUATERNARY AMMONIUM SALTS | UNION CARBIDE CORPORATION (US) | 1980-09-02 | — | — | US | disclosed |
| US-4111861-A | ELASTOMERS | UNION CARBIDE CORPORATION (US) | 1978-09-05 | — | — | US | disclosed |
| US-3946081-A | OXIDATION CATALYSTS, GROUP V, VI, OR VII OXIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-03-23 | — | — | US | disclosed |